Annual D&A
$14.56 M
-$4.89 M-25.15%
December 31, 2024
Summary
- As of March 13, 2025, VIR annual depreciation & amortization is $14.56 million, with the most recent change of -$4.89 million (-25.15%) on December 31, 2024.
- During the last 3 years, VIR annual D&A has risen by +$8.75 million (+150.54%).
- VIR annual D&A is now -25.15% below its all-time high of $19.45 million, reached on December 31, 2023.
Performance
VIR Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$2.89 M
-$10.00 K-0.35%
December 31, 2024
Summary
- As of March 13, 2025, VIR quarterly depreciation & amortization is $2.89 million, with the most recent change of -$10.00 thousand (-0.35%) on December 31, 2024.
- Over the past year, VIR quarterly D&A has dropped by -$1.37 million (-32.25%).
- VIR quarterly D&A is now -48.81% below its all-time high of $5.64 million, reached on March 31, 2023.
Performance
VIR Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$14.56 M
-$1.59 M-9.86%
December 31, 2024
Summary
- As of March 13, 2025, VIR TTM depreciation & amortization is $14.56 million, with the most recent change of -$1.59 million (-9.86%) on December 31, 2024.
- Over the past year, VIR TTM D&A has dropped by -$3.28 million (-18.40%).
- VIR TTM D&A is now -25.15% below its all-time high of $19.45 million, reached on December 31, 2023.
Performance
VIR TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
VIR Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.1% | -32.3% | -18.4% |
| 3 y3 years | +150.5% | -48.8% | +34.0% |
| 5 y5 years | +222.3% | -48.8% | +34.0% |
VIR Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -25.1% | +150.5% | -48.8% | +89.7% | -25.1% | +150.5% |
| 5 y | 5-year | -25.1% | +222.3% | -48.8% | +147.9% | -25.1% | +222.3% |
| alltime | all time | -25.1% | +3270.1% | -48.8% | +185.2% | -25.1% | +1338.6% |
Vir Biotechnology Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $14.56 M(-25.2%) | $2.89 M(-0.3%) | $14.56 M(-9.9%) |
| Sep 2024 | - | $2.90 M(-32.0%) | $16.15 M(-9.5%) |
| Jun 2024 | - | $4.26 M(-5.7%) | $17.84 M(-2.7%) |
| Mar 2024 | - | $4.52 M(+0.8%) | $18.33 M(-5.8%) |
| Dec 2023 | $19.45 M(+186.8%) | $4.48 M(-2.3%) | $19.45 M(+14.9%) |
| Sep 2023 | - | $4.59 M(-3.4%) | $16.93 M(+20.7%) |
| Jun 2023 | - | $4.75 M(-15.8%) | $14.02 M(+29.0%) |
| Mar 2023 | - | $5.64 M(+188.7%) | $10.87 M(+60.2%) |
| Dec 2022 | $6.78 M(+16.7%) | $1.95 M(+16.1%) | $6.78 M(+6.8%) |
| Sep 2022 | - | $1.68 M(+5.4%) | $6.35 M(+3.2%) |
| Jun 2022 | - | $1.60 M(+2.8%) | $6.16 M(+3.3%) |
| Mar 2022 | - | $1.55 M(+2.0%) | $5.96 M(+2.6%) |
| Dec 2021 | $5.81 M | $1.52 M(+2.4%) | $5.81 M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $1.49 M(+6.0%) | $5.63 M(+1.0%) |
| Jun 2021 | - | $1.40 M(0.0%) | $5.57 M(+0.6%) |
| Mar 2021 | - | $1.40 M(+4.7%) | $5.54 M(+1.8%) |
| Dec 2020 | $5.44 M(+20.5%) | $1.34 M(-6.4%) | $5.44 M(+3.3%) |
| Sep 2020 | - | $1.43 M(+4.6%) | $5.27 M(+4.4%) |
| Jun 2020 | - | $1.37 M(+4.7%) | $5.04 M(+4.9%) |
| Mar 2020 | - | $1.31 M(+12.2%) | $4.81 M(+6.5%) |
| Dec 2019 | $4.52 M(+63.9%) | $1.16 M(-3.6%) | $4.52 M(+34.7%) |
| Sep 2019 | - | $1.21 M(+6.6%) | $3.35 M(+56.3%) |
| Jun 2019 | - | $1.13 M(+12.0%) | $2.15 M(+112.0%) |
| Mar 2019 | - | $1.01 M | $1.01 M |
| Dec 2018 | $2.76 M(+538.0%) | - | - |
| Dec 2017 | $432.00 K | - | - |
FAQ
- What is Vir Biotechnology annual depreciation & amortization?
- What is the all time high annual D&A for Vir Biotechnology?
- What is Vir Biotechnology annual D&A year-on-year change?
- What is Vir Biotechnology quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Vir Biotechnology?
- What is Vir Biotechnology quarterly D&A year-on-year change?
- What is Vir Biotechnology TTM depreciation & amortization?
- What is the all time high TTM D&A for Vir Biotechnology?
- What is Vir Biotechnology TTM D&A year-on-year change?
What is Vir Biotechnology annual depreciation & amortization?
The current annual D&A of VIR is $14.56 M
What is the all time high annual D&A for Vir Biotechnology?
Vir Biotechnology all-time high annual depreciation & amortization is $19.45 M
What is Vir Biotechnology annual D&A year-on-year change?
Over the past year, VIR annual depreciation & amortization has changed by -$4.89 M (-25.15%)
What is Vir Biotechnology quarterly depreciation & amortization?
The current quarterly D&A of VIR is $2.89 M
What is the all time high quarterly D&A for Vir Biotechnology?
Vir Biotechnology all-time high quarterly depreciation & amortization is $5.64 M
What is Vir Biotechnology quarterly D&A year-on-year change?
Over the past year, VIR quarterly depreciation & amortization has changed by -$1.37 M (-32.25%)
What is Vir Biotechnology TTM depreciation & amortization?
The current TTM D&A of VIR is $14.56 M
What is the all time high TTM D&A for Vir Biotechnology?
Vir Biotechnology all-time high TTM depreciation & amortization is $19.45 M
What is Vir Biotechnology TTM D&A year-on-year change?
Over the past year, VIR TTM depreciation & amortization has changed by -$3.28 M (-18.40%)